A study of Ang II serum levels in a cohort of 112 patients with COVID-19 reported a decrease in Ang II levels that was more pronounced in patients with ARDS and in non-survivors (Ozkan et al., 2021). This evidence concerns the gene AGT and acute respiratory distress syndrome.